Latest 30 News in the Life Sciences Industry
GlobeNewswire
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12 Jun 2026
GlobeNewswire
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11 Jun 2026
GlobeNewswire
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
08 Jun 2026
PR Newswire Association LLC.
A New Lease of Life: Stories of Hope, Survivorship and Second Chances with Apollo Hospitals
08 Jun 2026
GlobeNewswire
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04 Jun 2026
PR Newswire Association LLC.
Mesenchymal Stem Cells Market Forecast 2031: 12%+ CAGR, Growing Clinical Research & Regenerative Medicine Applications to Drive Market Expansion, Says Mordor Intelligence
04 Jun 2026
GlobeNewswire
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03 Jun 2026
GlobeNewswire
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
01 Jun 2026
GlobeNewswire
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
01 Jun 2026
GlobeNewswire
Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
31 May 2026
GlobeNewswire
New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength
26 May 2026
GlobeNewswire
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
21 May 2026
GlobeNewswire
Prana IV Therapy Highlights Emerging Research on Magnesium’s Role in Stress and Neurological Function
19 May 2026
GlobeNewswire
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
17 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
GlobeNewswire
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07 May 2026
GlobeNewswire
Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting
07 May 2026
PR Newswire Association LLC.
Micro Imaging Technology is pleased to Announce the Acquisition of Cellmyx
05 Jun 2026
PR Newswire Association LLC.
Apollo Hospitals Chennai Performs World's First Robotic Cancer Surgery for Lymph Node Removal Using Hugo RAS Platform via Lateral Approach
29 May 2026
PR Newswire Association LLC.
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan
22 May 2026
PR Newswire Association LLC.
Apollo Hospitals Brings Advanced Super Speciality Care to the Heart of Mumbai with New Centre in Dadar
13 May 2026
PR Newswire Association LLC.
Apollo Hospitals introduces first of its kind advanced bone regeneration solution for diabetic and complex bone infections
05 May 2026
PR Newswire Association LLC.
Syngene strengthens leadership team with two key appointments
04 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
30 Apr 2026
PR Newswire Association LLC.
From South America to South India: A Young Life Stands Tall Again After Complex Robotic Spine Surgery
23 Apr 2026
Latest News All News
Upcoming Events All Events
- June 2026
- San Diego: RESI San Diego 2026
- San Diego: BIO 2026
- July 2026
- Taipei: BIO Asia-Taiwan